Introduction {#s1}
============

It has been a long recognised hallmark of mammalian gene expression patterns that there are extremely high levels of transcription and transcriptome complexity in testicular cells ([@bib14]; [@bib33]; [@bib54]; [@bib45]; [@bib64]; [@bib9]; [@bib23]; [@bib67]). These high gene expression levels are thought to result from epigenetic changes that favour relaxed patterns of gene expression during meiosis -- the unique form of division used to generate sperm and eggs ([@bib54]). Many nuclear RNA-binding proteins are differentially expressed during and immediately after meiosis ([@bib22]; [@bib47]). These include the nuclear RNA binding protein RBMXL2 (also known as hnRNP GT) that is expressed only during and immediately after male meiosis, but not in the preceding spermatogonial cells ([@bib18]) ([Figure 1A](#fig1){ref-type="fig"}). Consistent with an important function in germ cell development, genetic studies have identified point mutations within infertile men in the human chromosome 11 *RBMXL2* gene ([@bib66]). A further connection to male infertility is that *RBMXL2* belongs to the same gene family as *RBMY*, which was historically the first human Y chromosome infertility gene identified in the search for the *AZF* (*AZOOSPERMIA FACTOR*) gene ([@bib37]).

![Creation of a mouse model which does not express the testis-specific RNA binding protein RBMXL2.\
(**A**) The *RBMXL2* gene evolved via retrotransposition of *RBMX* early in mammalian evolution. The cladogram shows three members of the gene family that derived from an ancestral *RBMX* gene, summarising their global functions, expression, and RNA binding sites of their encoded proteins. (**B**) Modular structure of the RBMXL2 protein, showing the known protein interaction with Tra2β. (**C**) Western blot confirming no RBMXL2 protein is made within 2 replicate samples of *Rbmxl2*^-/-^ adult testis, compared to wild type (*Rbmxl2*^+/+^) and heterozygous (*Rbmxl2^+/-^*) adult testes.](elife-39304-fig1){#fig1}

*RBMXL2* evolved \~65 million years ago via retrotransposition of an mRNA from the X chromosome located RBMX gene ([Figure 1A](#fig1){ref-type="fig"}). An *RBMXL2* gene is found in all placental mammals, which is consistent with a fundamental role in germ cell biology. This role remains to be identified, but RBMXL2 protein has an N-terminal RNA Recognition Motif (abbreviated RRM, [Figure 1B](#fig1){ref-type="fig"}). RBMX and RBMY proteins are also nuclear RNA binding proteins that are very similar to RBMXL2 (73.2% and 36.8% overall identity to RBMX and RBMY, respectively; 93.7% and 77.2% identity within the RRMs, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). The RNA binding specificity of RBMXL2 protein is unknown, but both RBMX and RBMY proteins bind to AA dinucleotide-containing RNA sequences ([@bib10]; [@bib42]; [@bib43]). The RBMXL2, RBMX and RBMY proteins interact with and modulate the splicing activity of Tra2β and SR proteins in vitro ([Figure 1B](#fig1){ref-type="fig"}) ([@bib10]; [@bib42]; [@bib35]; [@bib43]; [@bib20]), suggesting a role in splicing control. Maintaining proper ratios of mRNA splice isoforms can be critical in normal development ([@bib27]), where changes in isoforms can have effects on encoded proteins ranging from major to subtle. Alternative splicing is known to be critical for germ cell development. For example, deletion of the splicing regulator protein PTBP2 within germ cells affects mRNA isoforms important for cell-cell communication with Sertoli cells ([@bib24]). Some alternative splicing events in the testis are conserved between humans and mice so may control fundamental aspects of germ cell biology ([@bib47]). However many alternative splicing patterns are not conserved between humans and mice ([@bib28]). RBMX protein is also reported to control transcription ([@bib57]), affect DNA double strand repair and mitotic sister chromatid cohesion ([@bib2]; [@bib40]), and to bind to m6A methylated RNA ([@bib36]).

The function of RBMXL2 and why this RNA binding protein has been conserved across placental mammals are not known. A major factor limiting understanding of endogenous RBMXL2 functions has been the absence of a reliable mouse model. Development of a mouse model is also critical to test the importance of this wider family of RNA binding proteins in germ cell development. Men carrying the *AZFb* deletion on their Y chromosomes are missing *RBMY* genes and undergo meiotic arrest. However, it is unclear if *RBMY* loss is causing this phenotype, because the deletion interval encompasses several other genes which could contribute to male infertility ([@bib19]; [@bib62]). Within the meiotic and immediately post-meiotic germ cells which express RBMXL2, the *RBMX* and *RBMY* genes are transcriptionally inactivated within a heterochromatic structure called the XY body ([@bib63]). Meiosis thus provides a genetically tractable window to probe RBMXL2 function where there should be no redundancy effects possible with either RBMX or RBMY. Hence to discover what RBMXL2 does in the germline we have made a conditional *Rbmxl2* gene knockout mouse. Analysis of this knockout mouse reveals that RBMXL2 protein is essential for meiosis and has a major role in protecting the meiotic transcriptome from aberrant selection of cryptic splice sites that are normally ignored by the spliceosome. Our data suggest this fundamentally important process operates so efficiently in meiosis that it has been previously undetected, yet is critical to avoid male infertility caused by aberrant splicing of key meiotic transcripts.

Results {#s2}
=======

RBMXL2 protein is essential for male fertility {#s2-1}
----------------------------------------------

To test how important RBMXL2 protein is for male germline development we made a conditional mouse model in which we flanked the *Rbmxl2* open reading frame with *LoxP* sites. Since *Rbmxl2* is only expressed in the testis ([@bib21]), we chose to delete the entire *Rbmxl2* open reading frame to create a null allele. We achieved this by crossing our conditional model with a mouse strain expressing *Cre* recombinase under control of the ubiquitous *Pgk* promoter (experimental details are provided in the Materials and methods). We confirmed deletion of this genomic region in homozygous *Rbmxl2* gene knockout (*Rbmxl2*^-/-^) mice by Southern blotting ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}) and the specific absence of the 50 KDa RBMXL2 protein from knockout testes by Western blotting ([Figure 1C](#fig1){ref-type="fig"}).

*Rbmxl2*^-/-^ mice developed comparably to their wild type littermates but their testes were much smaller ([Figure 2A and B](#fig2){ref-type="fig"}). This small testis phenotype correlated with a severe disruption of testicular histology. Adult *Rbmxl2*^-/-^ mice contained cells undergoing meiosis but almost no post-meiotic cells ([Figure 2C](#fig2){ref-type="fig"}, meiotic spermatocytes are abbreviated Spc, and post-meiotic round spermatids are abbreviated Rtd). The epididymis dissected from *Rbmxl2*^-/-^ mice were completely devoid of sperm. Four wild type mice tested had an average of 7.07 ± 1.39×10^6^ epididymal sperm ml^−1^, compared with zero in four *Rbmxl2*^-/-^ mice ([Figure 2D and E](#fig2){ref-type="fig"}). No effect on female fertility was observed in *Rbmxl2*^-/-^ mice (not shown).

![RBMXL2 protein is important for mouse germ cells to progress past diplotene into metaphase I of meiosis.\
(**A**) Testis morphologies of adult wild type and homozygous knockout (*Rbmxl2*^-/-^) mice (scale above testes shown in millimeters). (**B**) Testis:body weight ratios of different genotype mice. P values were calculated using a t test. (**C**) Micrographs of haemotoxylin-stained testis sections from wild type and *Rbmxl2*^-/-^ mice. Abbreviations: Spg, spermatogonia; Spc, spermatocyte; Rtd, round spermatid; Spd, elongating spermatid. Scale bar = 20 um. (**D**) Epididymis of wild type and *Rbmxl2*^-/-^ mice stained with haemotoxylin and eosin. Asterisk indicates lumen (note lumen is empty in *Rbmxl2*^-/-^ section indicative of azoospermia, but contains multiple cells in the wild type). Scale bar = 20 um. (**E**) Epididymal sperm counts of wild type and *Rbmxl2*^-/-^ mice (n = 4 of each genotype). The error bar represents SEM. (**F**) Meiotic prophase I stages detected in wild type and *Rbmxl2*^-/-^ testis chromosome spreads stained for SYCP3 (pseudocoloured red) and SYCP1 (pseudocoloured green); and DAPI and SYCP3 (pseudocoloured blue and red respectively). No metaphase I nuclei were identified in the *Rbmxl2*^-/-^ testes. Quantitative data are provided in [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}.](elife-39304-fig2){#fig2}

Very rarely a few round spermatids were observed in adult *Rbmxl2*^-/-^ testis sections ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), although no elongated spermatids were detected. The presence of these round spermatids indicates that meiosis can occasionally complete in the absence of RBMXL2 protein. This is consistent with loss of RBMXL2 causing either (1) a developmental block in meiosis from which a few cells can escape; or alternatively (2) a slow attrition effect, in which the *Rbmxl2*^-/-^ testis phenotype is caused by post-meiotic stages dying in the adult testis. To differentiate between these two possibilities we histologically analysed testes at 21 days postpartum (21dpp), at which point germ cells in the wild type (*Rbmxl2* ^+/+^) mice have just started to enter the post-meiotic round spermatid stage. At 21dpp there were still significantly fewer round spermatids in the *Rbmxl2*^-/-^ sections compared to wild type ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}), even though there would have been less time for round spermatid cell death compared with the adult. This result thus supports a strong meiotic block in *Rbmxl2*^-/-^ mice, with occasional completion of meiosis rather than a gradual attrition of round spermatids.

Most *Rbmxl2*^-/-^ germ cells do not progress past meiotic diplotene {#s2-2}
--------------------------------------------------------------------

The above data demonstrate that an *Rbmxl2* gene, which is conserved in all placental mammals and specifically expressed in male meiosis, is essential for mouse spermatogenesis somewhere within meiotic prophase. Staining of nuclear spreads with antibodies specific to the meiotic chromosome proteins SYCP1 and SYCP3 more precisely showed that *Rbmxl2*^-/-^ mice arrest germ cell development during the diplotene substage of meiotic prophase ([Figure 2F](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Metaphase I nuclei were only detected in wild type mice and not in *Rbmxl2*^-/-^ mice (N = 3 wild type and N = 3 *Rbmxl2*^-/-^testes, 180 and 138 spermatocyte nuclei scored for wild type and *Rbmxl2*^-/-^ respectively). No significant differences in the frequency of earlier stages of meiotic prophase were detected between *Rbmxl2*^-/-^ and wild type testes. The presence of germ cell populations up to diplotene in *Rbmxl2*^-/-^ testes was further confirmed by analysis of histological sections stained with Periodic Acid Schiff (PAS) ([Figure 2---figure supplement 3A--D](#fig2s3){ref-type="fig"}). Staining of adult testis sections with PAS or antibodies specific to the apoptotic marker activated Caspase three further showed that adult *Rbmxl2*^-/-^ germ cells die via apoptosis ([Figure 2---figure supplement 3E--F](#fig2s3){ref-type="fig"}).

Analysis of diplotene nuclear spreads revealed further abnormalities in the *Rbmxl2*^-/-^ testis. There was a decreased number of H3K9me3-marked centromere clusters ([@bib56]), with each individual cluster also containing more centromeres than in wild type testis ([Figure 2---figure supplement 4A--C](#fig2s4){ref-type="fig"}). H3K9me3 staining was also present at the sex body in a proportion (82%) of wild type diplotene spermatocytes, but essentially absent in mutant diplotene spermatocytes (1.5% of diplotene spermatocytes stained, 66 *Rbmxl2*^-/-^ and 66 wild type nuclei scored, n = 3 for both) ([Figure 2---figure supplement 4D](#fig2s4){ref-type="fig"}). These defects in centromere clustering and H3K9me3 modification of the sex body were still detectable but less severe at pachytene ([Figure 2---figure supplement 4D](#fig2s4){ref-type="fig"}). Asynapsis was rarely observed in either control or mutant pachytene stage spermatocytes, indicating that the defect causing diplotene arrest does not significantly impact either synaptonemal complex formation or meiotic homology searching ([Figure 2---figure supplement 4E](#fig2s4){ref-type="fig"}) (N = 3, 109 and 94 nuclei scored for wild type and *Rbmxl2*^-/-^ respectively).

In summary, the above mouse phenotype showed that deletion of the ancient RNA binding protein RBMXL2 induces progressive defects in male mouse meiotic prophase. These defects culminate with a major block during diplotene that prevents entry into metaphase I, but with defects becoming already apparent during pachytene.

Gene expression analysis of age matched wild type and *Rbmxl2*^-/-^ testes {#s2-3}
--------------------------------------------------------------------------

Since RBMXL2 is a nuclear RNA binding protein we predicted that the above phenotype could be associated with a primary molecular defect in generating or processing RNAs in the *Rbmxl2*^-/-^ testis. To test this we analysed wild type and *Rbmxl2*^-/-^ testes using RNAseq. Based on the knockout phenotype above, and because the adult wild type testis contains additional more advanced germ cells that are missing from the adult *Rbmxl2*^-/-^ testis, we analysed testes at 18 days post partum (18dpp) during the first synchronised wave of mouse spermatogenesis. Such 18dpp wild type mouse testes contain germ cells between spermatogonia all the way through to diplotene, with 60% of cells engaged in meiotic prophase, but no post-meiotic cells ([@bib5]).

Gene expression analysis of this RNAseq data ([@bib3]) showed overall patterns of transcription were similar between wild type and *Rbmxl2*^-/-^ 18dpp testes ([Figure 3A](#fig3){ref-type="fig"}, and [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). Only 45 genes showed a fold change greater or equal to two between the wild type and *Rbmxl2*^-/-^ testes, with an adjusted p value of less than 0.05, and only 23 of these changes were for known protein coding genes ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). The strongest difference in overall gene expression between the wild type and *Rbmxl2*^-/-^ backgrounds was for the *Rbmxl2*^-/-^ gene itself, as expected since the *Rbmxl2*^-/-^ gene is deleted from the knockout mouse. We also detected strong expression changes within the *Fsip2* gene, particularly for *Fsip2* exon 16 and downstream exons that were expressed only in the wild type background ([Figure 3---figure supplement 1A and B](#fig3s1){ref-type="fig"}). Mutations in *Fsip2* correlate with defects in human sperm flagella -- cellular structures which develop after meiosis ([@bib39]). RNAseq analysis detected more subtle expression changes in *Cul4a*, *Slc9c1* and *Tex15*, each of which are required for mouse male fertility ([@bib52]) ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}) ([@bib30]). Genes encoding transcription factors (*Myf6* and *Nxn*) and a signalling protein (*Cyr61*) that controls apoptosis ([@bib26]) also changed expression. Mouse phenotype information at the Mouse Genome Database (MGD) ([@bib52]) indicate that each of these latter three genes have important roles in normal development but not specifically of the testis ([Figure 3---source data 2](#fig3sdata2){ref-type="supplementary-material"}). Sixteen (36% of the total detected) gene expression changes in the *Rbmxl2*^-/-^ testis were for predicted non coding RNAs of unknown function ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}).

![RBMXL2 protein expression controls splicing patterns of important genes during meiosis.\
(**A**) MAplot showing gene expression levels in 18dpp testis transcriptomes and how they change between wild type and *Rbmxl2*^-/-^ mice. Genes with more than a 2-fold change in gene expression, and an adjusted p value of less than 0.05 are shown as red dots. All other genes are shown as black dots. This data given in full within [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}. (**B**) Scatterplot showing splicing changes between the wild-type and *Rbmxl2*^-/-^ testis detected by RNA-seq. The scatterplot shows expected percentage of exonic segment inclusion, or E(PSI) for wild-type and *Rbmxl2*^-/-^ testis detected by RNA-seq using the bioinformatics programme MAJIQ ([@bib59]). Splicing changes in some genes are named and arrowed. High-confidence splicing changes (P(\|ΔPSI\| \> V)\>95%) are marked in dark red for a predicted change of V = 20%, and dark yellow for a predicted change of V = 10%, and are also listed in [Figure 3---source data 2](#fig3sdata2){ref-type="supplementary-material"} All other quantified splice changes are in yellow (21,280 events examined). Dashed lines indicate ΔPSI of +/- 10%. (**C**) Left pie chart: Proportions of genes identified by RNAseq analysis to have defects at the splicing and transcriptional levels. Right pie chart: Proportions of phenotypes reported by whole gene knockout annotated for genes detected to have splicing defects in the absence of RBMXL2 protein ([@bib52]) (see also [Figure 3---source data 6](#fig3sdata6){ref-type="supplementary-material"}). (**D**) The top 10 most frequently recovered pentamers after HITS-CLIP for RBMXL2 in the adult mouse testis (AA dinucleotides are shown in red).\
10.7554/eLife.39304.015Figure 3---source data 1.Complete list of gene expression changes between the 18dpp testes of wild type and *Rbmxl2*^-/-^ testes detected by DESeq.\
10.7554/eLife.39304.016Figure 3---source data 2.MGI mouse phenotypes reported by the Mouse Genome Database ([@bib52]) after whole gene knockout for RBMXL2 transcription targets.\
10.7554/eLife.39304.017Figure 3---source data 3.Complete list of 237 high-confidence, mis-regulated local splicing variations in 186 genes between wild type and *Rbmxl2*^-/-^ testes detected by Majiq ([@bib59]).\
10.7554/eLife.39304.018Figure 3---source data 4.PCR primers used to analyse splicing events by RT-PCR that change between wild type and *Rbmxl2*^-/-^ testes.Some genes have more than one regulated event. The coloured cells represent events in a gene also occurring in duplicate on the list.\
10.7554/eLife.39304.019Figure 3---source data 5.Gene Ontology (GO) terms for RBMXL2 splicing targets identified.GO terms were obtained from the Mouse Genome Database ([@bib52]).\
10.7554/eLife.39304.020Figure 3---source data 6.MGI mouse phenotypes reported after whole gene knockout for RBMXL2 splicing targets.Phenotypes were obtained from the Mouse Genome Database ([@bib52]).\
10.7554/eLife.39304.021Figure 3---source data 7.List of RBMXL2 target genes that are already implicated in mouse development.Summary of GO terms and MGI phenotypes of genes that are regulated at the splicing level by RBMXL2 (compiled from [Figure 3---source datas 5](#fig3sdata5){ref-type="supplementary-material"} and [6](#fig3sdata6){ref-type="supplementary-material"}).](elife-39304-fig3){#fig3}

RBMXL2 protein controls splicing patterns during meiosis {#s2-4}
--------------------------------------------------------

We carried out further bioinformatic analysis to specifically search for mis-regulated splicing events in the *Rbmxl2*^-/-^ testes ([@bib59]). A total of 237 high-confidence, mis-regulated local splicing variations were identified in 186 genes ([Figure 3B](#fig3){ref-type="fig"}, and [Figure 3---source data 3](#fig3sdata3){ref-type="supplementary-material"}). Using RT-PCR to distinguish splice isoforms 27 of these splicing changes were experimentally tested, validating 23/27 splice isoform switches ([Figure 3---source data 4](#fig3sdata4){ref-type="supplementary-material"}). Some genes had more than one splicing event controlled by RBMXL2 (e.g. the *Catsperb* gene had three events). Gene Ontology (GO) analysis showed that a number of the genes regulated at the splicing level by RBMXL2 have established roles in spermatogenesis, meiosis and germ cell development ([Figure 3---source data 5](#fig3sdata5){ref-type="supplementary-material"}). However, amongst the complete set of regulated genes there was no significant enrichment of particular GO terms. This is consistent with RBMXL2 regulating splicing of a functionally diverse group of genes. Analysis of knockout phenotypes provided by the MGD ([@bib52]) indicated that whole gene deletion of 25/186 RBMXL2-regulated genes cause male infertility. These latter target genes must thus have a key role in germ cell development ([Figure 3C](#fig3){ref-type="fig"}, [Figure 3---source data 6](#fig3sdata6){ref-type="supplementary-material"}, [Figure 3---source data 7](#fig3sdata7){ref-type="supplementary-material"}). Genetic deletion of some other RBMXL2 target genes cause either embryonic or neonatal lethality (33/186 genes), developmental (19/36 genes) or pleiotropic defects (43/186 genes). Cell type mis-splicing of these latter genes during meiosis could thus cause severe phenotypic effects on germ cell biology.

Fourteen (33%) of the genes originally identified to have changed overall expression levels between wild type and *Rbmxl2*^-/-^ testes also changed splicing patterns ([Figure 3C](#fig3){ref-type="fig"}, and [Figure 3---source datas 1](#fig3sdata1){ref-type="supplementary-material"} and [3](#fig3sdata3){ref-type="supplementary-material"}). These included splice variants in *Esco1* (encoding a protein involved in chromatid cohesion), *Slc39a8* (that encodes the transporter protein responsible for cadmium toxicity in the testis) ([@bib13]); and the *Slc9c1* gene (annotated on the MGD as essential for male fertility \[[@bib52]\]).

The RNA binding specificity of RBMXL2 protein was unknown. Thus we used high throughput sequencing cross linking immunoprecipitation (HITS-CLIP) to enable us to correlate splicing changes detected within the *Rbmxl2*^-/-^ 18dpp mouse testis with global RBMXL2 protein-RNA interactions ([@bib22]). Antibodies specific to mouse RBMXL2 immuno-precipitated a radiolabelled RNA protein adduct of the known size of RBMXL2 protein (50 KDa) after treatment with high concentrations of RNase ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}) ([@bib21]). Lower concentrations of RNase were used to retrieve an average tag length of 40 nucleotides. Enriched motif analysis of the sequenced RBMXL2 CLIP tags showed that each of the top 10 5-mers contained the dinucleotide AA ([Figure 3D](#fig3){ref-type="fig"}). Interestingly, AA is also the dinucleotide bound by RBMX ([@bib42]), which is consistent with over 90% shared sequence identity within the RRMs of these proteins ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). These intragenic cross-linked sites mapped to the mouse genome most frequently within introns, consistent with RBMXL2 being involved in nuclear RNA-processing events ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}). Next we searched for CLIP tags mapping to regions near the splicing events controlled by RBMXL2, which would suggest direct regulation. We observed enrichment of RBMXL2 binding both within alternative exon sequences and in regions proximal to regulated splice sites compared to non-regulated events ([Figure 3---figure supplement 3A](#fig3s3){ref-type="fig"}). Consistent with these enriched binding occurrences, motif maps of the top pentamers identified by CLIP ([Figure 3D](#fig3){ref-type="fig"}) showed regions of enrichment proximal to regulated versus non-regulated splice junctions ([Figure 3---figure supplement 3B](#fig3s3){ref-type="fig"}).

RBMXL2 protein represses splicing of exons that would compromise meiotic gene expression {#s2-5}
----------------------------------------------------------------------------------------

Overall, the above bioinformatics analysis indicated an accumulation of defective splice isoform patterns in the *Rbmxl2*^-/-^ testis. MAJIQ captures local splicing variations (LSVs) that involve both known and un-annotated (de-novo) splice sites, junctions and exons. These LSVs can correspond to both classical binary splicing events and more complex events involving three or more junctions. Since classical binary events (e.g. skipped exons) are easier to inspect and visualise with the RNAseq reads on the UCSC genome browser, we focused on the binary events for further investigation. This showed that 60% of the 87 most easily visualised classical splicing events controlled by RBMXL2 involve the altered selection of de-novo splice sites (defined as not currently annotated on the most recent build of the *Mus musculus* genome GRCm38/mm10, [Figure 3---source data 3](#fig3sdata3){ref-type="supplementary-material"}). These de-novo splicing variations controlled by RBMXL2 are putatively cryptic events as they insert novel internal exons that were flanked by consensus GT-AG 5\' and 3\' splice sites. Moreover, these de-novo splice sites showed low expected percent spliced in (E(PSI)) values in wild type 18 dpp testes and across a panel of twelve mouse tissues, further suggesting they are cryptic events only included in the absence of RBMXL2 and not in wild type mice ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Detailed investigation indicated 84% of such cryptic exons were either not multiples of three or introduced stop codons into their mRNAs, meaning their insertion into mRNAs would disrupt protein reading frames and interfere with meiotic protein expression.

Splicing inclusion of cryptic terminal exons could also severely impact patterns of meiotic gene expression. We detected high inclusion of a cryptic terminal exon within the 5′ UTR of the *Kdm4d* gene ([Figure 4A and B](#fig4){ref-type="fig"}, note also increased splicing of an already annotated upstream *Kdm4d* alternative exon within the *Rbmxl2*^-/-^ testis). We confirmed splicing inclusion of this *Kdm4d* cryptic exon in the *Rbmxl2*^-/-^ testes using RT-PCR (primer positions are shown in [Figure 4A](#fig4){ref-type="fig"}). *Kdm4d* encodes a histone demethylase protein that is important for normal patterns of germ cell apoptosis in the testis ([@bib25]). Exon two contains the entire CDS (Coding DNA Sequence, [Figure 4A](#fig4){ref-type="fig"}) of the *Kdm4d* gene. Analysis of exon junction read numbers using Sashimi plots confirmed different nuclear processing pathways are used for *Kdm4d* in wild type and knockout testes ([Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}). There were 14-fold more exon junction reads connecting *Kdm4d* exon one to the cryptic exon (140 reads), when compared to exon junction reads joining the cryptic exon to *Kdm4d* coding exon 2. This pattern is consistent with splicing inclusion of the cryptic exon being connected with use of an associated polyA site. Consistent with this, some individual RNAseq reads extended past the 5′ splice site of the *Kdm4d* cryptic exon and then terminated downstream following a consensus polyadenylation site (AATAAA) sequence ([Figure 4C](#fig4){ref-type="fig"}). Both bioinformatics analysis ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}) and qPCR ([Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}) detected reduced *Kdm4d* gene expression levels in each of 3 replicate *Rbmxl2*^-/-^ testes compared to their wild type equivalents, but these trends were not statistically significant due to biological variability between individual mice. We also detected increased selection in the *Rbmxl2*^-/-^ testes of another 17 splicing events that mapped to terminal exons ([Figure 3---source data 3](#fig3sdata3){ref-type="supplementary-material"}). These included an already annotated upstream terminal exon in the *Lrrcc1* gene (annotated on the MGD as essential for mouse fertility) ([@bib52]); and a terminal exon in the *Slc39a8* gene ([Figure 4---figure supplement 3A and B](#fig4s3){ref-type="fig"}).

![RBMXL2 protein represses splicing inclusion of exons that would compromise gene expression patterns.\
(**A**) Screenshot from the UCSC genome browser ([@bib29]) showing high inclusion levels for a novel cryptic exon in the *Kdm4d* gene in the *Rbmxl2*^-/-^ testis transcriptome. (**B**) Experimental confirmation of *Kdm4d* splicing changes using RT-PCR and capillary gel electrophoresis (lower panel), and data from 3 *Rbmxl2*^-/-^ and 3 wild type 18dpp mouse testes. Individual samples shown in the capillary gel electrophoretogram are indicated as red dots. The mean PSI is shown as a grey bar with SEM as error bar. The p value was calculated using a t test. (**C**) Higher resolution screenshot ([@bib29]) of the *Rbmxl2*^-/-^ testis transcriptome showing RNAseq read density in the genomic region of the *Kdm4d* cryptic exon. The position of the cryptic 5′ splice site is indicated by a red arrow. Splice junction sequences are shown underneath with the consensus polyadenylation site AATAAA in red. Some RNAseq reads terminate downstream of the *Kdm4d* cryptic exon 5′ splice site. The final RNAseq read coverage detected downstream of this exon is shown as a red asterix. (**D**) UCSC genome browser screenshot ([@bib29]) showing increased splicing selection of an cryptic 3′ splice site within the *Gm5134* mRNA in the *Rbmxl2*^-/-^ testis transcriptome. (**E**) Chart showing experimental confirmation of the splicing switch in the *Gm5134* gene in 3 *Rbmxl2*^-/-^ and 3 wild type 18dpp mouse testes. The individual samples shown in the capillary gel electrophoretogram are shown in the chart as red dots.](elife-39304-fig4){#fig4}

In addition to splicing of entire cryptic exons, loss of RBMXL2 protein also activated splicing selection of individual cryptic 5′ and 3′ splice sites within introns that increased the length of already annotated exons ([Figure 3---source data 3](#fig3sdata3){ref-type="supplementary-material"}). This kind of changed splicing pattern was observed for the *Gm5134* mRNA that encodes a solute transporter important for normal metabolism ([Figure 4D and E](#fig4){ref-type="fig"}). The aberrant splice isoform of the *Gm5134* transcript made in the *Rbmxl2*^-/-^ testis uses a cryptic 3′ splice site within intron 10, increasing the size of exon 11 by 1353nt.

RBMXL2 protein is important to prevent mis-splicing of long exons in key genes during meiosis {#s2-6}
---------------------------------------------------------------------------------------------

As well as cryptic splice sites within introns, some exon-located cryptic splice sites were activated within the *Rbmxl2*^-/-^ testes, including within genes important for testis development ([Figure 3---source data 6](#fig3sdata6){ref-type="supplementary-material"}). Amongst the genes known to be important for meiosis, we observed a dip in RNAseq density for the interior of *Meioc (meiosis specific gene with coiled coil domain)* exon five in the *Rbmxl2*^-/-^ testis transcriptome ([Figure 5A](#fig5){ref-type="fig"}) ([@bib1]; [@bib53]). This dip in RNAseq read density was caused by high levels of cryptic splice site activation within *Meioc* exon 5. Sashimi plots showed that in the *Rbmxl2*^-/-^testes \~ 28% of the splice junctions joined *Meioc* exon four to an exon-internal cryptic 3′ splice site within *Meioc* exon 5 ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). A further cryptic 5′ splice site within *Meioc* exon five was also used in 22% of the *Rbmxl2*^-/-^ testis transcripts. Use of both cryptic splice sites converted *Meioc* exon five into an exitron (an exon with internal splice sites) ([@bib38]; [@bib50]). RT-PCR analysis confirmed both these defective *Meioc* exon five splicing patterns within the *Rbmxl2*^-/-^ testes ([Figure 5B--C](#fig5){ref-type="fig"}).

![RBMXL2 protein is important to prevent splicing of long exons becoming disrupted during meiosis.\
(**A**) Screenshot from the UCSC genome browser ([@bib29]) showing splicing pattern of *Meioc* exon five in wild type and *Rbmxl2*^-/-^ testis. RNAseq read density from *Rbmxl2*^-/-^ testis are shown in blue; RNAseq read density from wild type testis in red; the genomic positions of HITS-CLIP tags are mapped underneath. Splice sites for exon five are arrowed, and the binding sites for RT-PCR primers are shown. (**B**) Representative capillary gel electrophoretogram showing RT-PCR validation of the changing *Meioc* splicing pattern. This RT-PCR analysis used three primers in multiplex (MeiocF- MeiocR1 detects splicing of exon 4 to exon 5, and MeiocF-MeiocR2 detects splicing from exon four to the cryptic 3′ splice site within exon 5, or splicing of exon 4 to exon five after complete exitron removal. Detection of full length *Meioc* exon five inclusion by this latter primer combination is precluded by the large size of the amplicon. (**C**) Chart showing percentage splicing inclusion (PSI) of different splice variants of *Meioc* exon 5. PSI data were generated by RT-PCR from three wild type (WT) and 3 *Rbmxl2*^-/-^ mice, with the individual samples shown in the capillary gel electrophoretogram in part (**B**) indicated as red dots. Error bars represent the SEM, and p values were calculated using t tests. (**D**) Western blot of 18dpp mouse testes protein probed with an antibody specific to Meioc protein ([@bib1]). A non-specific protein that was also detected in mouse spleen as well as 18dpp testis is indicated by an asterisk. (**E**) Capillary gel electrophoretogram showing patterns of *Meioc* exon 5 splicing between 10dpp and 21dpp in the first wave of mouse spermatogenesis. (**F**) UCSC screenshot ([@bib29]) showing that splicing of *Alms1* exon five is disrupted in *Rbmxl2*^-/-^ testes via selection of an internal 5′ splice site.](elife-39304-fig5){#fig5}

The cryptic splice sites within Meioc exon five are hardly ever used in the wild type 18dpp testis transcriptome. In silico analysis showed that the internal cryptic 5′ splice site within *Meioc* exon five is weak compared to 5′ splice sites for other known alternative exons (7.5^th^ percentile by SROOGLE, compared to 57^th^ percentile for the downstream annotated 3′ splice site ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}) ([@bib48]). The first two nucleotide positions downstream of the *Meioc* exon 5- cryptic internal 5′ splice site are GC, so diverge from the GT consensus which is found flanking almost all eukaryotic introns. Similarly, the cryptic internal 3′ splice site within *Meioc* exon five is relatively weak (8^th^ percentile of the average 3′ splice site strength for an alternative exon, compared to 41^st^ percentile for the upstream annotated 3′ splice site). *Meioc* exon five is also directly bound by RBMXL2 protein, evidenced by three internal HITS-CLIP tags ([Figure 5A](#fig5){ref-type="fig"}). These include a CLIP tag directly overlapping the *Meioc* exon 5 internal cryptic 5\' splice site, as well as CLIP tags upstream of the internal 3′ splice site.

*Meioc* exon five is highly conserved across species suggesting it encodes a functionally important part of Meioc protein ([Figure 5A](#fig5){ref-type="fig"}). Exitrons frequently modify protein coding capacity of mRNAs by removing peptide coding segments from mRNAs ([@bib38]; [@bib50]). Both the cryptic splicing events in Meioc exon five remove RNA segments within the *Meioc* CDS that are multiples of 3. These events shorten the CDS just upstream of but largely not including the coding information for the MEIOC domain itself (<http://pfam.xfam.org/family/PF15189>). We thus predicted that a shorter Meioc protein isoform may be produced in the *Rbmxl2*^-/-^ testis. Consistent with this, Western blotting with a Meioc specific antiserum ([@bib1]) detected a 40--50 KDa Meioc protein within the *Rbmxl2*^-/-^ testis, but not in wild type or heterozygote *Rbmxl2* ^±^testes ([Figure 5D](#fig5){ref-type="fig"}). This 40--50 KDa molecular weight corresponds to an expected Meioc protein size following complete exitron removal. Although shorter Meioc protein isoforms were only detected in the *Rbmxl2*^-/-^ testes, in each genotype we detected a protein doublet just above 100 KDa corresponding to the reported size of full length Meioc protein ([@bib1]) ([Figure 5D](#fig5){ref-type="fig"}).

We further analysed splicing patterns during the first wave of mouse spermatogenesis to test whether appearance of the *Meioc* splicing defects corresponded with the known expression window of RBMXL2 protein in meiotic prophase ([@bib18]). Aberrant splice isoforms of *Meioc* exon five only appeared within *Rbmxl2*^-/-^ testes from 14dpp, and were barely visible at any time point within similar age wild type testes. We performed similar experiments to analyse the dynamics of *Brca2* splicing in the first wave of mouse spermatogenesis. The RNAseq data predicted utilisation of an upstream cryptic 5′splice site within the 4809 nucleotide *Brca2* exon 11 ([Figure 3---source data 3](#fig3sdata3){ref-type="supplementary-material"}) that removes 1263 nucleotides from *Brca2* exon 11 in the *Rbmxl2*^-/-^ testes ([Figure 5---figure supplement 2A](#fig5s2){ref-type="fig"}). RT-PCR analysis during the first wave of spermatogenesis showed *Brca2* exon 11 splicing was normal at 13dpp in the *Rbmxl2*^-/-^ testes, with defects appearing only during and after 14dpp ([Figure 5---figure supplement 2B](#fig5s2){ref-type="fig"}). These time-course data indicate that splicing defects in both *Meioc* and *Brca2* appear and become progressively worse during meiotic prophase in the *Rbmxl2*^-/-^ testes within genes that are expressed and processed normally in earlier germ cell types. An implication of this is that the aberrant splice isoforms detected in 18dpp whole testis RNA must be significantly diluted by signals from germ cells from earlier developmental stages.

Other unusually long exons in genes important for germ cell development were also mis-spliced in the *Rbmxl2*^-/-^ testes including exons in the *Alms1* and *Esco1* genes ([Figure 3---source data 3](#fig3sdata3){ref-type="supplementary-material"}). The *Alms1* gene encodes a protein involved in microtubule organisation during cell division, and its knockout disrupts spermatogenesis resulting in a small testis phenotype ([@bib52]). In the *Rbmxl2*^-/-^ testis an upstream 5′splice site is selected within *Alms1* exon 5, which is is unusually long at 1546nt ([Figure 5F](#fig5){ref-type="fig"}). This splice switch removes 1407 nucleotides from the *Alms1* mRNA, and coding information for 469 amino acids from the predicted *Alms1* reading frame.

Ectopic expression of RBMXL2 protein represses cryptic exon splicing in vitro {#s2-7}
-----------------------------------------------------------------------------

The above data indicate that loss of RBMXL2 protein within spermatocytes activates utilisation of cryptic splice sites. We next tested if cryptic splice site selection would be reciprocally repressed by ectopic expression of RBMXL2 protein. The genomic region spanning the *Kdm4d* cryptic exon and its flanking intron sequences were cloned into a minigene ([Figure 6A](#fig6){ref-type="fig"}). We detected \~40% splicing inclusion of the cryptic *Kdm4d* exon after co-transfection of this minigene into HEK293 cells (that do not normally express RBMXL2) with an expression vector encoding GFP ([Figure 6B](#fig6){ref-type="fig"} lane 1). Levels of *Kdm4d* cryptic exon splicing inclusion were repressed 6-fold upon co-transfection of a construct encoding an RBMXL2-GFP fusion protein. We also tested the activity of an RBMXL2 fusion protein without the RNP1 motif of the RRM (RBMXL2 ΔRNP1). Consistent with RNA-protein contacts not being critical for splicing repression of this cryptic exon, RBMXL2 ΔRNP1 could still repress *Kdm4d* cryptic exon splicing, although slightly less efficiently than the full length RBMXL2 fusion protein. Interestingly, splicing of the *Kdm4d* cryptic exon was also efficiently silenced by ectopic co-expression of an RBMX-GFP fusion protein ([Figure 6B](#fig6){ref-type="fig"} lane 7).

![Ectopic expression of RBMXL2 protein represses cryptic exon splicing in vitro.\
(**A**) Schematic of the *Kdm4d* minigene, in which the *Kdm4d* cryptic exon and flanking introns (shown in blue) are inserted between two beta globin exons in the vector pXJ41 ([@bib7]). (**B**) Bar chart (upper panel) showing data from biological triplicate experiments after quantitation using capillary gel electrophoresis (n = 3 for each transfection). Capillary gel electrophoretogram (lower panel) showing splicing patterns in HEK293 cells. The minigene containing the *Kdm4d* cryptic exon and flanking intron sequences were transfected with expression plasmids encoding either GFP, RBMXL2, RBMXL2 ΔRNP1, Tra2β, RBMX or combinations of these. Splicing patterns were analysed using RT-PCR. (**C**) Bar chart showing average annotated and cryptic splice site strengths from a panel of internal cryptic exons that were activated in *Rbmxl2*^-/-^ testes. Splice site strengths were quantitated as a percentile of the average value for an alternative exon using Sroogle ([@bib48]). Open bars show percentile values for cryptic exons, shaded bars (black or red) show percentile values for downstream exons. Error bars represent the SEM, and p values were calculated using t tests.](elife-39304-fig6){#fig6}

The above results show that RBMXL2 represses *Kdm4d* cryptic exon splicing, and is consistent with RBMXL2 providing a direct functional replacement for RBMX during meiosis. iCLIP experiments in adult mouse testis further identified the *Kdm4d* cryptic exon as directly binding the splicing activator protein Tra2β (Dalgliesh and Elliott, unpublished data). Consistent with this, Tra2β over-expression in HEK293 cells strongly increased *Kdm4d* cryptic exon splicing inclusion ([Figure 6B](#fig6){ref-type="fig"} lane 4). Ectopic activation by Tra2β indicated that although this *Kdm4d* exon cryptic exon is effectively ignored by the spliceosome in wild type testis, cryptic exon splicing is activated in response to increased expression of a splicing activator protein. Importantly, splicing activation by Tra2β was efficiently supressed when the minigene was co-transfected at the same time with both RBMXL2 and Tra2β ([Figure 6B](#fig6){ref-type="fig"}, lanes 5 and 6).

We addressed if other cryptic exons repressed by RBMXL2 might also possess the capacity to be activated by splicing regulators that bind to their associated splicing enhancer sequences. In silico analysis ([@bib48]) of a panel of cryptic exons that were activated in the *Rbmxl2*^-/-^ testes showed that these exons had significantly weaker 3′ splice sites, but similar Exonic Splicing Enhancer (ESE) sequence content compared to their immediately adjacent downstream exons ([Figure 6C](#fig6){ref-type="fig"}). These other cryptic exons that are repressed by RBMXL2 may be likewise poised for splicing during meiosis, because they bind to splicing activator proteins such as Tra2β.

Discussion {#s3}
==========

This study finds that loss of the ancient RBMXL2 protein completely prevents sperm production in the mouse, largely because of a developmental block during meiosis. *Rbmxl2*^-/-^ mouse germ cells develop as far as meiosis, thus escaping the major developmental checkpoints that operate during meiotic pachytene ([@bib15]), but then undergo cell death by apoptosis after reaching diplotene. Our data further show that RBMXL2 protein is important to protect the meiotic transcriptome from a spectrum of splicing defects ([Figure 7A](#fig7){ref-type="fig"}). These include classic manifestations of cryptic splicing that would be strongly deleterious to gene expression ([@bib38]; [@bib50]), such as insertion of novel cryptic exons and premature polyadenylation sites that would disrupt protein coding sequences, and the selection of cryptic splice sites that would shorten or extend exon lengths. Previous work reporting poor conservation of splicing patterns between species suggested that alternative splicing might not control fundamental aspects of germ cell biology ([@bib28]). In contrast, the work presented here suggest a generic requirement for cryptic splice site suppression during meiosis that could explain the conservation of an *Rbmxl2* gene in all placental mammals, even if individual cryptic splice sites are not conserved between species' genomes ([@bib21]).

![RBMXL2 protein is needed to enable production of proper splice isoform patterns during meiosis.\
(**A**) Stacked bar chart summarising percentage types of splicing event mis-regulated in the *Rbmxl2*^-/-^ testes. Details of the individual genes contributing to this list are given in [Figure 3---source data 3](#fig3sdata3){ref-type="supplementary-material"}. (**B**) Models for RBMXL2 function. In wild type mice, RBMXL2 protein may block cryptic exon splicing through: 1. Inhibition of splicing regulator proteins including Tra2β protein via protein-protein interactions ([@bib60]); or 2. Direct RNA protein interactions of RBMXL2 with important splicing regulatory sequences in the pre-mRNA. In the *Rbmxl2*^-/-^ background the absence of this buffering would result in an increase in splicing inclusion of some cryptic exons which contain Tra2β binding sites.](elife-39304-fig7){#fig7}

Cells in meiotic prophase might be particularly susceptible to cryptic splice site poisoning because of their high levels of transcription, altered splicing regulator expression and relaxed chromatin environments ([@bib14]; [@bib33]; [@bib54]; [@bib45]; [@bib64]; [@bib9]; [@bib23]; [@bib67]). In silico data suggest that the cryptic exons repressed by RBMXL2 would be poised for splicing inclusion in conditions of high concentrations of splicing activators because of their strong ESE contents. We suggest a model where RBMXL2 protein may buffer the activity of splicing activator proteins to prevent such cryptic splice site selection from happening in meiosis ([Figure 7B](#fig7){ref-type="fig"}). This model is also consistent with previously reported data showing that RBMXL2, RBMX and RBMY proteins physically interact with and antagonise the splicing activity of Tra2β and SR proteins ([@bib35]; [@bib43]; [@bib60]; [@bib20]) ([Figure 7B](#fig7){ref-type="fig"}). Data presented in this study also show that *Kdm4d* cryptic exon splicing activation by Tra2β is blocked in vitro by co-expression of RBMXL2. As an alternative and not mutually exclusive model, RBMXL2 protein-RNA binding may sterically block recognition of some cryptic splice sites during meiosis, including the cryptic 5′ splice site within *Meioc* exon five which was utilised in the *Rbmxl2*^-/-^ testis ([Figures 5A](#fig5){ref-type="fig"} and [7B](#fig7){ref-type="fig"}). However, no HITS-CLIP tags for RBMXL2 were detected near the *Kdm4d* cryptic exon. Furthermore, a version of RBMXL2 deleted for the key RNP1 motif involved in RNA-protein interactions could still repress *Kdm4d* cryptic exon splicing (albeit slightly less efficiently than the wild type RBMXL2 protein). Thus buffering protein interactions between RBMXL2 and proteins like Tra2β may be potentially more important in repressing cryptic splicing in meiosis than direct RBMXL2 RNA-protein interactions.

Loss of RBMXL2 disrupts expression of many downstream target genes in parallel, both at splicing and transcriptional levels. This makes it difficult to resolve whether the phenotype detected in the *Rbmxl2*^-/-^ mouse testes is caused by aberrant expression of a single target RNA, or is a compound phenotype involving multiple genes. Some genes affected by RBMXL2 protein deletion are annotated as important for spermatogenesis on the MGD ([@bib52]). These include *Alms1* ([@bib4]; [@bib11]); *Brca2* which is required for meiotic prophase ([@bib49]); *Kdm4d*, which helps control apoptosis during male germ cell development ([@bib25]); and *Cul4a* that encodes an important ubiquitin ligase needed for DNA damage response. Two factors complicate direct comparison of MGD phenotypes with those after RBMXL2 knockout. Firstly, conventional knockouts will report a phenotype the first time a gene is needed in a developmental pathway. In contrast RBMXL2 is only expressed from the onset of meiosis, so any defects in target gene expression that occur without RBMXL2 could result in a later phenotype. For example, *Meioc* knockout phenotype analysis has concentrated on entry into meiosis ([@bib1]; [@bib53]). Our data show that *Meioc* exon five is still spliced normally on meiotic entry in the *Rbmxl2*^-/-^ mouse (at 12dpp), but becomes compromised later on during meiotic prophase (when RBMXL2 is expressed). It is possible that *Rbmx* and *Rbmy* will provide an equivalent function to *Rbmxl2* in spermatogonia and early spermatocytes, and that it is only when meiotic sex chromosome inactivation initiates during pachytene that germ cells will depend on *Rbmxl2*. Consistent with this, in transfected cells RBMX was able to suppress a cryptic splice exon in the *Kdm4d* with similar efficiency to the RBMXL2 protein. Secondly, the MGD phenotype data ([@bib52]) is after gene knockout, whereas Rbmxl2 deletion changes patterns of splice isoforms.

High levels of gene expression and alternative splicing have also been observed in the nervous system, and this is another anatomic site where pathological cryptic exon inclusion has been reported. Neuronal cryptic exon inclusion occurs following depletion of the splicing repressor protein TDP43, and might contribute to neuron death in neurological diseases like ALS and Alzheimer's disease ([@bib55]). Cryptic splicing has also been observed in cultured human cells after depletion of the splicing repressor proteins hnRNP C, hnRNPL and PTB ([@bib34]; [@bib41]; [@bib68]), and in mouse oocytes depleted for the splicing factor SRSF3 ([@bib16]). Taking all these results into consideration we suggest that RBMXL2 has a key role controlling the meiotic transcriptome, and suggest that human male infertility caused by loss of *RBMXL2* or its paralog RBMY may be associated with germ cell type-specific cryptic splicing.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\            Designation                        Source or reference           Identifiers                                                        Additional information
  (species) or resource                                                                                                                                        
  ------------------------ ---------------------------------- ----------------------------- ------------------------------------------------------------------ -------------------------
  Gene (M. musculus)       *Rbmxl2*                                                                                                                            

  Strain, strain\          C57Bl/6                                                                                                                             
  background\                                                                                                                                                  
  (M. musculus)                                                                                                                                                

  Genetic reagent\         *Rbmxl2* knockout                  this publication                                                                                 
  (M. musculus)                                                                                                                                                

  Genetic reagent\         FlpE                               [@bib46]                                                                                         
  (M. musculus)                                                                                                                                                

  Genetic reagent\         PGKcre                             [@bib31]                                                                                         
  (M. musculus)                                                                                                                                                

  Cell line (H. sapiens)   HEK293                                                                                                                              

  Antibody                 Sheep polyclonal\                  [@bib18]\                                                                                        (1:700)
                           anti-Rbmxl2                                                                                                                         

  Antibody                 Guinea pig\                        [@bib1]\                                                                                         (1:1000)
                           polyclonal anti-Meioc                                                                                                               

  Antibody                 Mouse monoclonal\                  Sigma                         catalog number\                                                    (1:1000)
                           anti-tubulin                                                     T6793                                                              

  Antibody                 Rabbit polyclonal\                 Abgent, San Diego CA          catalog number\                                                    (1:1000)
                           anti-GAPDH                                                       AP7873b                                                            

  Antibody                 Rabbit polyclonal\                 Proteintech                   catalog number\                                                    (1:100)
                           anti-caspase 3                                                   25546--1-AP                                                        

  Antibody                 Rabbit polyclonal\                 Life span                     Cat\# LS-B175,\                                                    (1:500)
                           anti-Sycp3                                                       RRID:[AB_2197351](https://scicrunch.org/resolver/AB_2197351);\     
                                                                                            lot\#73619                                                         

  Antibody                 Mouse monoclonal\                  Abcam                         Cat\#ab97672\                                                      (1:500)
                           anti-Sycp3 \[Cor 10G11/7\]                                       RRID:[AB_10678841](https://scicrunch.org/resolver/AB_10678841);\   
                                                                                            lot\#GR282926-1                                                    

  Antibody                 Guinea Pig polyclonal\             Laboratory of\                                                                                   (1:200)
                           anti-Sycp1                         Howard Cooke                                                                                     

  Antibody                 Mouse monoclonal\                  Millipore                     Cat\# 05--636,\                                                    (1:3000)
                           anti-phospho H2AX \[JBW301\]                                     RRID:[AB_309864](https://scicrunch.org/resolver/AB_309864);\       
                                                                                            lot\#1997719                                                       

  Antibody                 Rabbit polyclonal\                 Abcam                         Cat\# ab8898,\                                                     (1:500)
                           anti-H3 trimethyl K9                                             RRID:[AB_306848](https://scicrunch.org/resolver/AB_306848);\       
                                                                                            lot\# GR250850-2                                                   

  Antibody                 Mouse monoclonal\                  Abcam                         Cat\# ab14955,\                                                    (1:1000)
                           anti-H3 phospho (Ser10)                                          RRID:[AB_443110](https://scicrunch.org/resolver/AB_443110);\       
                                                                                            lot\# GR192274-8                                                   

  Antibody                 Human polyclonal\                  Antibodies Incorporated       Cat\#15-235-0001                                                   (1:50)
                           anti-Centromere Protein                                                                                                             

  Antibody                 Mouse monoclonal\                  From Katsuhiko Shirahige,\                                                                       (1:1000)
                           anti-AcSmc3                        University of Tokyo.\                                                                            
                                                              [@bib44]                                                                                         

  Antibody                 Goat polyclonal\                   Invitrogen                    Cat\# A11001                                                       (1:500)
                           anti-Mouse Alexa\                                                                                                                   
                           Fluor 488                                                                                                                           

  Antibody                 Goat polyclonal\                   Invitrogen                    Cat\#A11008                                                        (1:500)
                           anti-Rabbit Alexa\                                                                                                                  
                           Fluor 488                                                                                                                           

  Antibody                 Goat polyclonal\                   Invitrogen                    Cat\# A11013                                                       (1:500)
                           anti-Human Alexa\                                                                                                                   
                           Fluor 488                                                                                                                           

  Antibody                 Goat polyclonal\                   Invitrogen                    Cat\# A11073                                                       (1:500)
                           anti-Guinea Pig Alexa\                                                                                                              
                           Fluor 488                                                                                                                           

  Antibody                 Goat polyclonal\                   Invitrogen                    Cat\# A11005                                                       (1:500)
                           anti-Mouse Alexa\                                                                                                                   
                           Fluor 594                                                                                                                           

  Antibody                 Goat polyclonal\                   Invitrogen                    Cat\# A11012                                                       (1:500)
                           anti-Rabbit Alexa\                                                                                                                  
                           Fluor 594                                                                                                                           

  Antibody                 Goat polyclonal\                   Invitrogen                    Cat\# A32733                                                       (1:500)
                           anti-Rabbit Alexa\                                                                                                                  
                           Fluor 647                                                                                                                           

  Antibody                 Goat polyclonal\                   Invitrogen                    Cat\# A21450                                                       (1:500)
                           anti-Guinea Pig Alexa\                                                                                                              
                           Fluor 647                                                                                                                           

  Dye                      DAPI\                              Biotium                       Cat\# 40043;\                                                      
                           (4\',6-diamidino-2-phenylindole)                                 lot\# 15D1117                                                      

  Recombinant DNA\         PXJ41 Kdm4d                        this paper                                                                                       
  reagent                                                                                                                                                      

  Sequence-based\          primers                            this paper                                                                                       designed using Primer3\
  reagent                                                                                                                                                      <http://primer3.ut.ee/>

  Sequence-based\          qPCR primers                       this paper                                                                                       designed using Primer3\
  reagent                                                                                                                                                      <http://primer3.ut.ee/>

  Commercial\              Rnaeasy plus kit                   Qiagen                        catalog number 74134                                               
  assay or kit                                                                                                                                                 

  Commercial\              DNA free                           Ambion                        catalog number AM1906                                              
  assay or kit                                                                                                                                                 

  Commercial\              Superscript Vilo                   Invitrogen                    catalog number 11754                                               
  assay or kit                                                                                                                                                 

  Chemical\                Bouins                             Sigma                         catalog number HT10132                                             
  compound, drug                                                                                                                                               

  Software, algorithm      Graphpad prism                     <https://graphpad.com>                                                                           

  Software, algorithm      Sroogle                            <http://sroogle.tau.ac.il/>                                                                      
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Generation of KO mice {#s4-1}
---------------------

A targeting construct in which the *Rbmxl2* open reading frame was flanked by *LoxP* sites was made using standard molecular biology techniques, and electroporated into ES129 cells. Positive clones were injected into blastocysts to create chimaeras, and bred to yield agouti pups heterozygous for the targeted locus (Ozgene, Perth, Australia). The original mice containing the *Neomycin* gene ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}) were crossed to *FlpE* mice to remove the *Neo* gene and to generate the *Rbmxl2 ^LoxP^* conditional allele ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Mice containing the *Rbmxl2 ^LoxP^* conditional allele were crossed with mice expressing *PGKCre*, resulting in deletion of the *Rbmxl2* reading frame ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}). Genetic structures of the wild type and targeted alleles were confirmed by Southern blotting. Genomic DNA was prepared from mouse tails, cut with *BamHI*, run on an agarose gel and blotted onto a Hybond N nylon membrane (GE Healthcare, Little Chalfont, UK). Blots were probed using an internal probe Enp (generated using primers enpF 5′-ACTGTTGATTCCCCTTCCAAC-3′ and enp R 5′- ACTCCTGCCTGTGATTGGTC-3′, and α- ^32^ P labelled by random priming). The correct insertion of the targeting vector in the genome was confirmed by cutting genomic DNA with *Psh*A1 and *Eco*RV and hybridizing with 5′ (generated from genomic DNA using 5′-agcattcagcaaaggctcac-3′ and 5′- ttaaaactgagggagactgc-3′) and 3′ (generated from genomic DNA using 5′-actgcatagttgtagccatc-3′ and 5′- tgcattctctttaggctcatttc-3′) probes respectively.

Animal work {#s4-2}
-----------

Animal research was carried with the approval of the Newcastle University animal research ethics committee and the UK Government Home Office (Home Office project Licence Number PIL 60/4455).

Analysis of mouse germ cell development in vivo {#s4-3}
-----------------------------------------------

Testis/body weight ratios, and sperm counts were measured on a C57Bl6 background. In order to determine sperm counts, the cauda epididymis was dissected in PBS and the sperm were counted in a haemocytometer.

Preparation of RNA for RNA-Seq {#s4-4}
------------------------------

Mice were back crossed onto the C57Bl6 background for eight generations, and we used back crossed male mice for subsequent analysis. Testes were homogenized in RLTplus buffer from Qiagen before purification with the Rneasy plus kit (Qiagen, 74134). The RNA was then re-purified with the kit before Dnase digestion (Ambion).

RNA-Seq analysis {#s4-5}
----------------

Paired-end sequencing was done for six samples in total (three biological replicates of 18dpp wild-type and *Rbmxl2*^-/-^ testis) using 75 bp reads. Libraries were prepared using TruSeq Stranded mRNA Library Prep Kit (Illumina) and sequenced; 75 bp single reads were sequenced on a NextSeq 500 (Illumina, using the mid output v2 150 cycles kit). The base quality of the raw sequencing reads were checked using FastQC. Trimmomatic (v0.32) was used to remove adapters and to trim the first twelve bases and the last base at position 76 ([@bib6]). Reads were aligned to the UCSC D3c. 2011 (GRCm38/mm10) assembly of the mouse genome using STAR (v2.5.2b) ([@bib17]). Alternative splicing events were assessed using MAJIQ and VOILA software packages ([@bib59]). Briefly, uniquely mapped, junction-spanning reads were used by MAJIQ to construct splice graphs for transcripts from a custom Ensembl transcriptome annotation and to quantify PSI (within conditions) and ΔPSI (between conditions) for all local splicing variations (LSVs). The captured LSVs include classical alternative splicing events (e.g. cassette exons, alternative 5' splice sites, etc.) as well as more complex variations ([@bib59]). LSVs with an expected change of greater than 10% were then visualized using VOILA to produce splice graphs, violin plots representing PSI and ΔPSI quantifications, and interactive HTML outputs for changes between wild type and *Rbmxl2*^-/-^.

In silico analysis of mouse cryptic exons {#s4-6}
-----------------------------------------

Splicing patterns of identified target genes were analysed using the UCSC and IGV mouse genome browsers ([@bib29]; [@bib58]). A panel of 10 cryptic exons from the *Catsperb* (two exons), *Ccdc60*, *Kdm4d*, *Lrrcc63*, *4933409G03Rik*, *Tcte2*, *Ube2e2*, *Fam178b* genes) and their immediately downstream exons were monitored for strength of splicing sequences using Sroogle ([@bib48]). A panel of 19 exons were analysed for length and translation termination codons content (*1700074P13Rik*, *4833439L19Rik*, *ccdc60*, *Dnah12*, *Hmga2*, *Map2k5*, *Rbks*, *Tcte2*, *Ube2e2*, *4933409G03Rik*, *4930500J02Rik*, *4932414N04Rik*, *Fam178b*, *Ccdc144b*, *Ston1*, *Usp54*, *Lca5l*, and *Catsperb* and *Lca5l*).

Detection of splice isoforms in mouse testis RNA {#s4-7}
------------------------------------------------

The levels of different mRNA splice forms were detected in DNAse treated total RNA isolated from 18dpp mouse testes. cDNA was synthesised using superscript Vilo (Invitrogen) and PCR amplified, followed by either capillary gel electrophoresis (Qiaxcel) or agarose gel electrophoresis ([@bib22]). Gene-specific primers specific for different splice isoforms are given in [Figure 3---source data 4](#fig3sdata4){ref-type="supplementary-material"}.

Hits-clip {#s4-8}
---------

HITS-CLIP was performed as previously described ([@bib32]) using an antibody specific to RBMXL2 ([@bib18]). In short, for the CLIP analysis a single mouse testis was sheared in PBS and UV crosslinked. After lysis, the whole lysate was treated with DNase and RNase, followed by radiolabelling and linker ligation. After immunoprecipitation with purified antisera specific to RBMXL2 ([@bib18]), RNA bound RBMXL2 was separated on SDS-PAGE. A thin band at the size of 65 kDa (RBMXL2 migrates at around 50 kDa and MW of 50 nt RNA is about 15 kDa) was cut out and subject to protein digestion. RNA was recovered and subject to Illumina sequencing, and the reads were aligned to the mouse genome. HITS-CLIP tags mapped to 22,438 protein coding genes. HITS-CLIP data were further analysed to extract most frequently occurring pentamer nucleotide sequences within genes (ncRNA, ORF, 3'UTR, 5'UTR and intron). A window between +50 and −50 of the cross link site was analysed (to avoid crosslinking bias), and after correction for average pentamer occurrence in control sequences (as described in [@bib65]). Each pentamer was only counted once in the analysed window.

*Kdm4d* minigene analysis {#s4-9}
-------------------------

The *Kdm4d* cryptic exon and flanking intron sequences were PCR-amplified from mouse genomic DNA using the cloning primers Kdm4dF (5′-AAAAAAAAGAATTCCCACACAGCAAAACCCTCTC-3′) and Kdm4dR (5′-AAAAAAAAGAATTCGCCACCTTTTGCTATTCCTTT-3′). The PCR products were digested with *EcoR1* restriction enzyme and cloned into the pXJ41 vector using the *Mfe1* site midway through the 757 nucleotide β-globin intron ([@bib7]). Analysis of splicing patterns transcribed from minigenes was carried out in HEK293 cells as previously described ([@bib22]; [@bib61]) using primers within the β-globin exons of pXJ41, pXJ41F 5′-GCTCCGGATCGATCCTGAGAACT-3′) and pXJ41R (5′-GCTGCAATAAACAAGTTCTGCT-3′).

Detection of proteins in mouse testis {#s4-10}
-------------------------------------

For protein detection by immunohistochemistry, testes were fixed in Bouins, embedded in paraffin wax, sectioned and attached to glass slides. Sections were prepared and immunohistochemistry carried out as previously described ([@bib22]). Primary antibodies were specific to caspase 3, p17-specific (Proteintech Europe Ltd). Protein detection by Western was as previously described ([@bib22]) using primary antibodies specific to RBMXL2 ([@bib18]), Meioc ([@bib1]), and control antibodies specific to tubulin (Sigma T6793) and GAPDH (Abgent,San Diego CA, AP7873b).

Spermatocyte spreading {#s4-11}
----------------------

The tunica was removed from testes, and seminiferous tubules macerated with razor blades in a small volume of DMEM media. DMEM was added to 4 ml, and debris allowed to settle for 10 min. Cells were then pelleted from the suspension at 233 g for 5 min. The pellet was resuspended in 1--2 ml DMEM per animal. 5 drops of 4.5% sucrose were added to the centre of each clean glass slide using a Pasteur pipette. A single drop of the cell suspension was added to each slide from a height of 15--20 cm, followed by one drop of 0.05% Triton-X-100. The slides were incubated in a humid chamber for 10 min, then eight drops of fixative (2% PFA, 0.02% SDS, pH 8) were added to each slide, and incubated in humid chamber for 20 min. Slides were dipped in water to wash and allowed to air dry before storing at −80°C ([@bib12]).

Antibody staining and image capture {#s4-12}
-----------------------------------

Slides were blocked for one hour in 0.15% BSA, 0.1% Tween-20, 5% goat serum PBS, then incubated with primary antibodies for three hours at room temperature or 4°C overnight. Primary antibodies were used at the following concentrations, diluted in block solution: rabbit anti-Sycp3 (1:500, Lifespan Cat\# LS-B175 RRID:[AB_2197351](https://scicrunch.org/resolver/AB_2197351)), mouse anti-Sycp3 (1:500, Abcam Cat\# ab97672 RRID:[AB_10678841](https://scicrunch.org/resolver/AB_10678841)), guinea pig anti-Sycp1 (1:200, from Howard Cooke), mouse anti-γH2AX (1:3000; Millipore Cat\# 05--636, RRID:[AB_309864](https://scicrunch.org/resolver/AB_309864)), rabbit anti-H3K9me3 (1:500; Abcam Cat\# ab8898, RRID:[AB_306848](https://scicrunch.org/resolver/AB_306848)), mouse anti-phospho H3 (1:1000; Abcam Cat\# ab14955, RRID:[AB_443110](https://scicrunch.org/resolver/AB_443110)), human anti-centromere (1:50; Antibodies Incorporated, Cat\#15-235-0001), mouse anti-AcSmc3 (1:1000, a gift from Katsuhiko Shirage \[[@bib44]\]). Slides were washed three times for five minutes in PBS before incubating with 1:500 secondary antibodies and ng/ul DAPI (4\',6-diamidino-2-phenylindole) for one hour at room temperature in darkness. Slides washed again three times and mounted in 90% glycerol, 10% PBS, 0.1% p-phenylenediamine.

Images were captured with Micromanager imaging software using an Axioplan II fluorescence microscope (Carl Zeiss) equipped with motorised colour filters. Centromere and H3K9me3 staining was imaged by capturing z-stacks using a piezoelectrically-driven objective mount (Physik Instrumente) controlled with Volocity software (PerkinElmer). These images were deconvolved using Volocity, and a 2D image generated in Fiji.

Nuclei were staged by immunostaining for the axial/lateral element marker SYCP3. Pachytene nuclei were identified in this analysis by complete co-localisation of SYCP3 and either the transverse filament marker SYCP1 on all nineteen autosomes, or by the presence of nineteen bold SYCP3 axes in addition to two paired or unpaired sex chromosome axes of unequal length. Asynapsed pachytene nuclei were judged to be nuclei containing at least one fully synapsed autosome, and at least one autosome unsynapsed along \>50% of its length ([@bib12]).

Quantification and statistical analysis {#s4-13}
---------------------------------------

Quantification and statistical analyses were done using Graphpad (<http://www.graphpad.com/>).

Spermatocyte staining analysis {#s4-14}
------------------------------

All scoring of immunostained chromosome spreads was performed blind on images after randomisation of filenames by computer script. Three *Rbmxl2*^-/-^ and three wild type control animals were analysed for each experiment. Meiotic substaging analysis involved 179 nuclei from control animals, and 138 from *Rbmxl2*^-/-^ mice. Diplotene phospho-H3 analysis involved 128 control and 157 *Rbmxl2*^-/-^ nuclei, and the proportion of nuclei with bold centromeric signal was analysed using a Fisher's test. Pachytene asynapsis was measured in 108 control and 92 *Rbmxl2*^-/-^ nuclei, and the data analysed using a Fisher's test. Centromere positioning and H3K9me3 staining was assessed across 73 control and 65 *Rbmxl2*^-/-^pachytene nuclei, and 66 diplotene control and 66 *Rbmxl2*^-/-^ diplotene nuclei. These data were analysed using Wilcoxon Rank Sum test.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: the authors were asked to provide a plan for revisions before the editors issued a final decision. What follows is the editors' letter requesting such plan.\]

Thank you for sending your article entitled \"An ancient germ cell-specific RNA binding protein protects the germline from cryptic splice site poisoning\" for peer review at *eLife*. Your article is being evaluated by a Reviewing Editor, and three reviewers and the evaluation is being overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor.

Given the list of essential revisions, including new experiments, the editors and reviewers invite you to respond within the next two weeks with an action plan and timetable for the completion of the additional work. We plan to share your responses with the reviewers and then issue a binding recommendation.

In this manuscript, Ehrmann and colleagues characterize the germ cell-specific RNA binding protein hnRNP GT. The authors generated a conditional knockout mouse targeting hnRNP GT, and demonstrate significant defects in testis histology and spermatogenesis in mutant animals. Specifically, the authors demonstrate that defects in knockout animals likely stem from problems during a specific stage of meiosis. Given the observed phenotypes, transcriptome-wide analysis is performed looking both at steady-state mRNA levels as well as splicing patterns. The authors find both transcript-level and splicing-level differences between wild type and mutants, but their data suggest more prevalent defects in the latter layer of gene regulation. In particular, in addition to aberrant regulation of annotated alternative exons, the authors identify a more significant proportion of \'cryptic\'/minor splice sites being utilized in mutant animals, and the use of these splice sites are predicted to have deleterious effects on encoded protein products. Additional experiments include HITS-CLIP assays that determine the sequence binding preference of hnRNP GT (motifs with AA dinucleotides) and information about direct targets of this RNA binding protein. Finally, the authors show in cell lines that over-expression of hnRNP GT has the ability to suppress usage of a cryptic splice site, even in the context of co-expression of the activating SR protein Tra2β.

Overall, this is a carefully conducted investigation that should be of considerable interest to the readership of *eLife* after suitable revision. It is requested that authors provide a proposed plan for revisions that can be performed within approximately two months, based on the comments below. In particular, it was felt that the paper would be significantly strengthened by the inclusion of additional data supporting functional roles for the isoforms highlighted by the authors, and in this regard their plan should pay special attention to point 3 below. It was also felt that the section of the paper relating to functional consequences of isoform switches could be better focused and the authors should make an effort to revise this section accordingly.

Essential revisions:

1\) Subsection "hnRNP GT protein controls splicing patterns during meiosis". The manuscript states that 23 of 27 tested splicing events were validated, citing Source Data 3. But this file has no data -- only has a list of primers used for RT-PCR. It would be appropriate to include the results of the RT-PCR -- as PSI (mean {plus minus} sd) for WT and KO conditions, and to define how an event was defined as validated. Did validation only require a statistically significant change in the same direction as for RNA-Seq? Ideally show the RT-PCR values alongside the MAJIQ values for PSI.

The RT-PCR examples shown in Figure 4B, Figure 5B and Figure 5---figure supplement 2A,B, look convincing and do not need quantitation to be convincing. Nevertheless, it would be good to show the PSI numbers to allow direct comparison with the MAJIQ output.

2\) Many genes are identified with differences in overall transcript abundance and/or changes in alternatively spliced isoforms. The authors largely ignore the 45 genes identified with differences in RNA level between WT and KO testis. The authors should comment on these genes and provide information on what the encoded proteins do, and how changes in their levels (caused by hnRNP GT KO) might contribute to the meiotic defects observed.

3\) The analysis of alternative splicing changes is not explored in sufficient depth to provide insight into why KO germ cells arrest in meiosis. The authors focus on select examples of genes previously shown to be important for spermatogenesis and that also express alternatively spliced mRNAs in KO compared to WT testes. While these genes may be required for different aspects of spermatogenesis, the authors manuscript would be significantly strengthened if they can provide any evidence that the splicing changes induced by hnRNP GT loss negatively impact gene functions.

In this regard, the authors claim that \"...insertion of this Kdm4d cryptic exon disables Kdm4d gene expression\", citing the reduced read density on Kdm4d exon 2 shown in Figure 4A. I was not convinced that the splicing of the cryptic exon \'disables... gene expression\' for the following reasons. First, clearly there are reads mapping to the exon2 indicating that full length transcripts are being produced. Second, because of the different scales used in the top and bottom RPKM tracks, it is difficult to state unequivocally that there is an appreciable difference in read density on exon 2. Third, Kdm4d should be in the list of 45 genes with reduced RNA levels (it is not in Figure 3---source data 1). Fourth, there is no western blot data showing that Kdm4d levels are reduced in KO testes. As it stands, the RT-PCR analysis of Kdm4d (primers in exon 1 and 2) is not adequate given the argument that polyadenylation at the cryptic exon primarily leads to truncation of transcripts. The authors should perform qRT-PCR to confirm decreased levels of the conventional transcript and ideally a western blot to show reduced protein expression.

The second example that is presented is alternative splicing of 3\' terminal exons in Lrrcc1. The authors note that Lrrcc1 \"is essential for mouse fertility (Figure 4D\" but do not reference the publication. Do Lrrcc1 mutants have the same meiotic defect as hnRNP GT KO mice? In Figure 5, the authors describe changes in mRNA isoforms from the Meioc gene caused by activation of cryptic 3\' and 5\' splice sites. The authors spend a considerable amount of time carefully characterizing the splicing changes in Meioc mRNAs, but then ultimately indicate that \"Consistent with the RNAseq data, expression levels of this full length Meioc protein did not change in the knockout (Figure 5D).\" So again, I am left questioning whether the splicing in Meioc in hnRNP GT KO are functionally relevant and have any contribution to the hnRNP GT phenotype.

In light of these concerns it would greatly strengthen the authors\' manuscript if they can provide data that more strongly support roles for the aforementioned (or other splicing changes) in the phenotypes observed in their hnRNP GT ko mice.

4\) Whereas the RNAseq libraries are described in detail (ages, number of replicates, etc), there is scant information on the CLIP data. The authors are requested to add information on the age of samples, how many replicate tissues were used, how was the data processed and analyzed, how many genes have binding. It should also be mentioned how high-confidence binding sites were discriminated from experimental noise. Also, while AA-dinucleotides may be present in the top 10 pentamers, the quality of the CLIP information is unclear.

5\) RNA binding maps representing different classes of splicing event would enhance the presentation of the CLIP analysis. For example, it would be interesting to see how hnRNP GT binding correlates with regulatory outcome from the RNA-seq analysis both for cryptic splice sites and for canonical types of alternative splicing like exon skipping events. Are similar features observed regarding mode of binding and regulation?

6\) In Figure 6, the authors describe analysis of a minigene splicing reporter bearing the Kdm4d cryptic exon. A schematic of the minigene should be included in the Figure. The data shows that the cryptic exon is spliced in \~40% of reporter transcripts expressed in HEK293, and inclusion of the exon decreases significantly when hnRNP GT is expressed. A direct role for hnRNP GT in repressing the cryptic exon should be demonstrated by showing that mutation of AA dinucleotides abolishes hnRNP GT\'s ability to repress splicing (or bind the transcript).

Reviewer \#1:

hnRNP GT is a mammalian autosomal paralog of RBMX and RBMY that is expressed during spermatogenesis when RBMX and RBMY are switched off. Its importance in spermatogenesis is indicated by mutations associated with male infertility.

In this manuscript David Elliott and colleagues use a mouse hnRNPGT conditional knockout model. As anticipated a very specific spermatogeneis phenotype was observed within exactly the time-window when hnRNPGT, but not RBMX or RBMY, is expressed. After careful and systematic phenotyping, testis mRNA-Seq was carried out at timepoint when the primary defect caused by hnRNPGT knockout could be observed (at later timepoints, the different cell-type compositions resulting from the initial phenotype would have dominated the signal). This showed that hnRNPGT deletion led to a large number of alternative splicing changes, with a strong enrichment for non-annotated (ie cryptic) events. The majority of cases would lead to down-regulated protein expression/activity, suggesting a compound phenotype arising from reduced expression of numerous proteins that are important during meiosis.

Overall, this is a carefully conducted investigation, clearly presented, which should be of interest to the readership of *eLife*.

Subsection "hnRNP GT protein controls splicing patterns during meiosis".. The manuscript states that 23 of 27 tested splicing events were validated, citing Source Data 3. But this file has no data -- only has a list of primers used for RT-PCR. It would be appropriate to include the results of the RT-PCR -- as PSI (mean {plus minus} sd) for WT and KO conditions, and to define how an event was defined as validated. Did validation only require a statistically significant change in the same direction as for RNA-Seq? Ideally show the RT-PCR values alongside the MAJIQ values for PSI.

The RT-PCR examples shown in Figure 4B, Figure 5B and Figure 5---figure supplement 2A,B, all look very convincing and do not need quantitation to be convincing. Nevertheless, it would be good to show the PSI numbers to allow direct comparison with the MAJIQ output.

Reviewer \#2:

In this report, Ehrmann et al., examine the functions of the RNA binding protein hnRNP GT in spermatogenesis. This protein is highly conserved across \~65 million years of evolution, is expressed during the meiotic and post-meiotic steps of spermatogenesis, and its' in vivo roles have remained poorly understood.

The authors demonstrate that deletion of the hnRNP GT results in a major arrest of germ cell development during prophase of meiosis, with very few cells surviving to the post-meiotic (spermatid) stage. More detailed analyses indicate that most germ cells lacking hnRNP GT arrest at the diplotene stage of meiotic prophase. Experiments characterizing the phenotype of hnRNP GT knockout mice (KO) are well executed and interpreted reasonably.

To understand what gene expression events are altered in the absence of hnRNP GT, the authors perform RNA-Seq analysis on biologic triplicate testes from wild type (WT) and knockout (KO) mice collected at postnatal day 18. In contrast to the phenotypic analyses, I was disappointed with the RNA analyses described in the paper, as well as the authors\' interpretation of the data.

1\) Many genes are identified with differences in overall transcript abundance and/or changes in alternatively spliced isoforms. The authors largely ignore the 45 genes identified with differences in RNA level between WT and KO testis. There is no rationale presented for doing so. There are no descriptions of what the encoded proteins do, and how changes in their levels (caused by hnRNP GT KO) might contribute to the meiotic defects observed. Instead, the authors end this section rather abruptly and move on to the analysis of splicing changes. Why are these gene expression changes dismissed? This was somewhat surprising given that the authors mention (in the introduction) a role for RBMX in controlling transcription patterns.

2\) Similarly, the analysis of alternative splicing changes are not explored in sufficient depth to provide new insight into why KO germ cells arrest in meiosis. Instead, the authors focus on the presentation of select examples of genes previously shown to be important for spermatogenesis and that also express alternatively spliced mRNAs in KO compared to WT testes. While these genes may be required for different aspects of spermatogenesis, there is no data presented to show that the splicing changes induced by hnRNP GT loss negatively impact gene functions.

The first of the examples presented is Kdm4d, in which loss of hnRNP GT results in splicing of a cryptic exon. The authors claim that \"...insertion of this Kdm4d cryptic exon disables Kdm4d gene expression\", citing the reduced read density on Kdm4d exon 2 shown in Figure 4A. I was not convinced that the splicing of the cryptic exon \'disables... gene expression\' for the following reasons. First, clearly there are reads mapping to the exon2 indicating that full length transcripts are being produced. Second, because of the different scales used in the top and bottom RPKM tracks, it is difficult to state unequivocally that there is an appreciable difference in read density on exon 2. Third, Kdm4d should be in the list of 45 genes with reduced RNA levels (it is not in Figure 3*---*source data 1). Fourth, there is no western blot data showing that Kdm4d levels are reduced in KO testes.

The second example that is presented is alternative splicing of 3\' terminal exons in Lrrcc1. The authors note that Lrrcc1 \"is essential for mouse fertility (Figure 4D\" but do not reference the publication. Do Lrrcc1 mutants have the same meiotic defect as hnRNP GT KO mice? The magnitude of the splicing change in Lrrcc1 is modest, as most AS changes tend to be. I\'m not criticizing the authors for this, but unless the authors can show that this splicing change impacts Lrrcc1 function or germ cell progression through prophase, I am left shrugging my shoulders. The same can be said for references to Slc39a8.

In Figure 5, the authors describe changes in mRNA isoforms from the Meioc gene caused by activation of cryptic 3\' and 5\' splice sites. The authors spend a considerable amount of time carefully characterizing the splicing changes in Meioc mRNAs, but then ultimately indicate that \"Consistent with the RNAseq data, expression levels of this full length Meioc protein did not change in the knockout (Figure 5D).\" So again, I am left questioning whether the splicing in Meioc in hnRNP GT KO are functionally relevant and have any contribution to the hnRNP GT phenotype.

To conclude point 2, unless the authors can show that the highlighted splicing examples shown are biologically important and contribute to the hnRNP GT phenotype, the significance is doubted, particularly for Meioc, whose protein levels are reportedly unaltered.

3\) Whereas the RNAseq libraries are described in detail (ages, number of replicates, etc), there is scant information on the CLIP data. What age was this performed on, how many replicate tissues, how was the data processed and analyzed, how many genes have binding? There is no mention of how high-confidence binding sites are discriminated from experimental noise. Thus, while AA-dinucleotides may be present in the top 10 pentamers, the quality of the CLIP information is unclear.

4\) In Figure 6, the authors describe analysis of a minigene splicing reporter bearing the Kdm4d cryptic exon. A schematic of the minigene should be included in the Figure. The data shows that the cryptic exon is spliced in \~40% of reporter transcripts expressed in HEK293, and inclusion of the exon decreases significantly when hnRNP GT is expressed. A direct role for hnRNP GT in repressing the cryptic exon should be demonstrated by showing that mutation of AA dinucleotides abolishes hnRNP GT\'s ability to repress splicing (or bind the transcript).

5\) The authors claim that hnRNP GT has a major role in protecting the meiotic transcriptome from aberrant selection of cryptic splice sites that are normally ignored by the spliceosome. While this may be a role, it\'s not clear that it is a major role. My reservation comes from the way in which these splicing events were selected. The authors state that \"60% of the 87 most clearly visualized classical splicing events controlled by hnRNP GT involved the altered selection of cryptic splice sites.\" What is a \'clearly visualized\' splicing event? 60% of 87 is 52, meaning that 52/237 splicing events (or 22% total) are cryptic splicing events.

6\) \"the poor conservation of splicing patterns between species has previously suggested alternative splicing might not have a major role in controlling fundamental aspects of germ cell biology (Kan et al., 2005).\" The referenced paper compares human and mouse splicing across tissues. Besides meiosis, there are considerable differences in the mitotic and post-meiotic stages of spermatogenesis between human and mouse. Furthermore, several labs, including the corresponding author\'s, have provided strong evidence indicating important roles for regulated alternative splicing events in germ cell development. The authors should reference these studies.

In summary, Ehrmann and colleagues demonstrate that hnRNP GT is required for sperm formation, and hnRNP GT loss is associated with changes in RNA levels and alternatively spliced isoforms. However, the data is not explored in sufficient depth to link these two main observations, nor does it provide information on the mechanism(s) by which hnRNP GT functions on different RNAs. As a result, the data does not break new ground and the manuscript is not likely to appeal to the broad readership of *eLife*.

Reviewer \#3:

In this manuscript, Ehrmann and colleagues characterize the germ cell-specific RNA binding protein hnRNP GT. The authors generated a conditional knockout mouse targeting hnRNP GT, and demonstrate significant defects in testis histology and spermatogenesis in mutant animals. Specifically, the authors demonstrate that defects in knockout animals likely stem from problems during a specific stage of meiosis. Given the observed phenotypes, transcriptome-wide analysis is performed looking both at steady-state mRNA levels as well as splicing patterns. The authors find both transcript-level and splicing-level differences between wild type and mutants, but their data suggest more prevalent defects in the latter layer of gene regulation. In particular, in addition to aberrant regulation of annotated alternative exons, the authors identify a more significant proportion of cryptic splice sites being utilized in mutant animals, and the use of these splice sites are predicted to have deleterious effects on encoded protein products. Additional experiments include HITS-CLIP assays that determine the sequence binding preference of hnRNP GT (motifs with AA dinucleotides) and information about direct targets of this RNA binding protein. Finally, the authors show in cell lines that over-expression of hnRNP GT has the ability to suppress usage of a cryptic splice site, even in the context of co-expression of the activating SR protein Tra2β.

Overall, I found the study very interesting and well executed, with very clean results and convincing phenotypes. It remains an important goal for continued characterization of RNA binding proteins in tissue- and context-specific alternative splicing, and relative to other tissues like the nervous system and muscle cells, there is comparatively little known about germ cell regulators of splicing.

I have only a few points that would be nice to see addressed by the authors:

1\) The authors indicate that hnRNP GT, RBMX and RBMY are paralogs. It would be nice to see a sequence alignment of all three proteins from various species to better visualize this. For example, what type of conservation is observed over relevant domains in the three RNA binding proteins?

2\) RNA maps would be nice to include as part of the CLIP analysis, perhaps separated by class of splicing event. For example, it would be interesting to see how hnRNP GT binding correlates with regulatory outcome from the RNA-seq analysis both for cryptic splice sites and for canonical types of alternative splicing like exon skipping events. Are similar features observed regarding mode of binding and regulation?

3\) Should all of the \'cryptic\' splice sites really be annotated as \'cryptic\'? This is perhaps more about semantics, but it sounds like the authors define cryptic splice sites as anything that is not annotated in the mm10 gene annotations. However, most RNA-seq data (even from wild type animals) will identify novel junctions often not documented in existing annotations on databases (especially tissue-specific isoforms which are often functional).

Perhaps this is just a matter of semantics, but in my opinion, cryptic splicing would involve novel splice sites that are never detected in wild type animals, as opposed to minor isoforms that are still found in wild type animals.

Some clarification from the authors would be nice regarding this point regardless of what they decide to call these variants. Specifically, are the majority of the cryptic events they detect in mutants completely absent in wild type animals, or are they detectable in wild type, just at low abundance?

10.7554/eLife.39304.036

Author response

\[Editors' notes: the authors' response after being formally invited to submit a revised submission follows.\]

> In this manuscript, Ehrmann and colleagues characterize the germ cell-specific RNA binding protein hnRNP GT. The authors generated a conditional knockout mouse targeting hnRNP GT, and demonstrate significant defects in testis histology and spermatogenesis in mutant animals. Specifically, the authors demonstrate that defects in knockout animals likely stem from problems during a specific stage of meiosis. Given the observed phenotypes, transcriptome-wide analysis is performed looking both at steady-state mRNA levels as well as splicing patterns. The authors find both transcript-level and splicing-level differences between wild type and mutants, but their data suggest more prevalent defects in the latter layer of gene regulation. In particular, in addition to aberrant regulation of annotated alternative exons, the authors identify a more significant proportion of \'cryptic\'/minor splice sites being utilized in mutant animals, and the use of these splice sites are predicted to have deleterious effects on encoded protein products. Additional experiments include HITS-CLIP assays that determine the sequence binding preference of hnRNP GT (motifs with AA dinucleotides) and information about direct targets of this RNA binding protein. Finally, the authors show in cell lines that over-expression of hnRNP GT has the ability to suppress usage of a cryptic splice site, even in the context of co-expression of the activating SR protein Tra2β.
>
> Overall, this is a carefully conducted investigation that should be of considerable interest to the readership of eLife after suitable revision. It is requested that authors provide a proposed plan for revisions that can be performed within approximately two months, based on the comments below. In particular, it was felt that the paper would be significantly strengthened by the inclusion of additional data supporting functional roles for the isoforms highlighted by the authors, and in this regard their plan should pay special attention to point 3 below. It was also felt that the section of the paper relating to functional consequences of isoform switches could be better focused and the authors should make an effort to revise this section accordingly.
>
> Essential revisions:
>
> 1\) Subsection "hnRNP GT protein controls splicing patterns during meiosis". The manuscript states that 23 of 27 tested splicing events were validated, citing Source Data 3. But this file has no data -- only has a list of primers used for RT-PCR. It would be appropriate to include the results of the RT-PCR -- as PSI (mean {plus minus} sd) for WT and KO conditions, and to define how an event was defined as validated. Did validation only require a statistically significant change in the same direction as for RNA-Seq? Ideally show the RT-PCR values alongside the MAJIQ values for PSI.
>
> The RT-PCR examples shown in Figure 4B, Figure 5B and Figure 5---figure supplement 2A,B, look convincing and do not need quantitation to be convincing. Nevertheless, it would be good to show the PSI numbers to allow direct comparison with the MAJIQ output.

Good suggestion, we added this data to the paper as an extra column to Figure 3*---*source data 4, so it is right next to the primers.

> 2\) Many genes are identified with differences in overall transcript abundance and/or changes in alternatively spliced isoforms. The authors largely ignore the 45 genes identified with differences in RNA level between WT and KO testis. The authors should comment on these genes and provide information on what the encoded proteins do, and how changes in their levels (caused by hnRNP GT KO) might contribute to the meiotic defects observed.

We now add this extra information and discuss the transcriptional changes in the text as requested. There are some interesting genes in the list of transcriptional changes. These include Cul4a, constitutive knockout of which causes a meiotic phenotype, and Fsip2 which encodes a component of the sperm midpiece. We also added qPCR analysis here to confirm gene expression changes of Fsip2 (new Figure 3*---*figure supplement 1). We agree with the reviewer that addition of this extra material makes our analysis much more complete. We also discuss how constitutive knockouts of genes needed in late meiosis may arrest at earlier stages in germ cell development if they are also needed earlier. This means that later stages will be invisible in terms of the knockout phenotype (please see also below).

> 3\) The analysis of alternative splicing changes is not explored in sufficient depth to provide insight into why KO germ cells arrest in meiosis. The authors focus on select examples of genes previously shown to be important for spermatogenesis and that also express alternatively spliced mRNAs in KO compared to WT testes. While these genes may be required for different aspects of spermatogenesis, the authors manuscript would be significantly strengthened if they can provide any evidence that the splicing changes induced by hnRNP GT loss negatively impact gene functions.
>
> In this regard, the authors claim that \"...insertion of this Kdm4d cryptic exon disables Kdm4d gene expression\", citing the reduced read density on Kdm4d exon 2 shown in Figure 4A. I was not convinced that the splicing of the cryptic exon \'disables... gene expression\' for the following reasons. First, clearly there are reads mapping to the exon2 indicating that full length transcripts are being produced. Second, because of the different scales used in the top and bottom RPKM tracks, it is difficult to state unequivocally that there is an appreciable difference in read density on exon 2. Third, Kdm4d should be in the list of 45 genes with reduced RNA levels (it is not in Figure 3---source data 1). Fourth, there is no western blot data showing that Kdm4d levels are reduced in KO testes. As it stands, the RT-PCR analysis of Kdm4d (primers in exon 1 and 2) is not adequate given the argument that polyadenylation at the cryptic exon primarily leads to truncation of transcripts. The authors should perform qRT-PCR to confirm decreased levels of the conventional transcript and ideally a western blot to show reduced protein expression.

We agree with the reviewer that from just the UCSC screenshot originally shown (Figure 4 in the manuscript) that this Kdm4d cryptic exon does not stand out as a terminal exon. We also carried out more detailed analysis of junction reads. This supports our interpretations, and we now incorporate this extra data into

the manuscript (in the new Figure 4---figure supplement 2). In the Sashimi plot

(Figure 4---figure supplement 2A), all wild type junction reads (71) join directly exon 1 to exon 2 (wild type sample shown in red, knockout sample shown in blue, and the Kdm4d gene reads from right to left). In contrast, the knockout sample shows a more complex pattern across the first intron. Importantly, almost all the reads terminate at the cryptic exon. There are 140 reads joining exon 1 to the cryptic exon. Only 10 junction reads join the cryptic exon to exon 2. Although we only show data for one knockout and one wild type mouse on the Sashimi plot, we saw the same patterns for exon junction reads for each of the knockout mice and wild type mice. The most straightforward conclusion to this exon junction read pattern is that the Kdm4d cryptic exon operates as a terminal exon.

In our expression analysis shown in Figure 3A, Kdm4d shows a log2 fold change in expression of -0.96 with a p value of 0.00048, but the padj value is 0.129 so this did not qualify for significance. We now provide the full table of expression levels between wild type and knockout for all genes as source data (see new Figure 3*---*source data 1). The lack of statistical significance is because of biological variability between mice. We also tested expression of Kdm4d exon 2 using qPCR. A decrease in Kdm4d exon 2 expression was detected across all knockout compared to wild type mice (new Figure 4---figure supplement 2B). Similar to the DESeq analysis this did not reach statistical significance, but it illustrates that the trend was the same in all 3 knockout mice.

Published antibodies raised against mouse Meioc enabled us to detect a shorter

protein isoform only in the knockout and not in the wild type or heterozygote (see also below). However, there is in general lack of validated antibodies against the mouse proteins that we would like to investigate. There is an Abcam antibody reported to react with mouse Kdm4d, but the single paper that used it does not show a Western of Kdm4d protein. We proposed in our action plan to obtain a new commercial (Proteintech) antibody specific for BRCA2 that is predicted to recognize mouse BRCA2 protein (384KDa). We tested this antibody by Western, but it mainly detected proteins of 250KDa and 70KDa even in wild type testis - much smaller than that corresponding to the expected size of full length BRCA2 protein. These data raise questions about the specificity of this antibody in mice, so we have not included this data in our revised manuscript.

> The second example that is presented is alternative splicing of 3\' terminal exons in Lrrcc1. The authors note that Lrrcc1 \"is essential for mouse fertility (Figure 4D\" but do not reference the publication. Do Lrrcc1 mutants have the same meiotic defect as hnRNP GT KO mice?

In our updated manuscript we have made it clearer how we accessed the MGI and IMPC phenotypes, by referring to the Mouse Genome Database. For example, Lrrcc1 has a male infertile phenotype from the mouse knockout project (http://www.ensembl.org/Mus_musculus/Gene/Phenotype?db=core;g=ENSMUSG00 000027550;r=3:14533788-14572658). We cite the Smith el al., 2018. This paper is about the database which we used to get the information, not specifically about just Lrrcc1 itself. We also made it clearer in our revised text that (1) the testis phenotype characterisation available for gene knockouts available via MGI and IMKP are not as detailed as we have performed for Hnrnpgt, so it is difficult to side by side compare them; and that (2) because of its expression profile, Hnrnpgt is likely to be most important for control of its target genes well after meiotic prophase has started --even if these target genes are also expressed earlier in germ cell development. In contrast, the mouse knockout phenotypes reported at MGD are often constitutive knockouts, so will arrest germ cell development the first time that the target gene is needed --often earlier than late prophase. For example, the phenotype of the constitutive Meioc knockout mouse has focussed on meiotic entry, well before late meiotic prophase when the Hnrnpgt KO mouse has a phenotype. So while Meioc is needed early in meiosis, a later role in meiosis is currently been invisible within the Meioc knockout mouse. Hence the published constitutive knockout does not tell us how impairing the function of Meioc during late pachytene would affect spermatogenesis. We also discuss the possibility that Rbmx and Rbmy could provide an equivalent function to Hnrnpgt that operates in spermatogonia and early spermatocytes, and that it is only when meiotic sex chromosome inactivation kicks in during pachytene that any critical non-redundant functions of Hnrnpgt will become apparent. We tested RBMX protein control of the Kdm4d cryptic exon in our revised Figure 6B.

> In Figure 5, the authors describe changes in mRNA isoforms from the Meioc gene caused by activation of cryptic 3\' and 5\' splice sites. The authors spend a considerable amount of time carefully characterizing the splicing changes in Meioc mRNAs, but then ultimately indicate that \"Consistent with the RNAseq data, expression levels of this full length Meioc protein did not change in the knockout (Figure 5D).\" So again, I am left questioning whether the splicing in Meioc in hnRNP GT KO are functionally relevant and have any contribution to the hnRNP GT phenotype.
>
> In light of these concerns it would greatly strengthen the authors\' manuscript if they can provide data that more strongly support roles for the aforementioned (or other splicing changes) in the phenotypes observed in their hnRNP GT ko mice.

The referee raises the important point of what is the importance of the

cryptic spliced isoforms if the normal mRNAs are also expressed in the testis. We

think this comes down to which cells express particular isoforms, and have carried out more experimental analysis to address this. Since hnRNP GT is only expressed in meiotic prophase, and its knockout has a late prophase arrest, we considered whether the correctly spliced Meioc exon 5 detected in total testis RNA could originate from the many cell types that exist before prophase. If this was the case, then the normal splicing signal from earlier germ cell types would make a significant contribution to swamping out the signal detected from aberrant splicing patterns in later germ cell types (including cells in diplotene).

We tested this by monitoring whether levels of cryptic splicing patterns become

stronger as the cell types that depend more exclusively on hnRNP GT expression

appear. This time-course data is shown in the new Figure 5E, and shows that

cryptic splicing of Meioc exon 5 does get progressively worse during meiotic

prophase. The normal splice isoform of Meioc was strongly expressed in the 10-

13dpp testis, with the shorter isoforms virtually invisible. 13dpp testis contain type B spermatogonia, preleptotene spermatocytes, zygotene spermatocytes and cells entering pachytene (Bellve et al., 1977). Just 3 days later, cryptic splicing patterns are easily detectable within 16dpp testes (which contain cells within pachytene, as well as the type B spermatogonia, preleptotene spermatocytes, zygotene spermatocytes found in 13dpp testis). These data support a model where cryptic Meioc splicing occurs within the specific cell types that rely on hnRNP GT for RNA processing, and that the normal splice isoform signal in whole testis RNA must be coming at least in part from earlier germ cell types before meiotic prophase.

Likewise, the shorter Meioc protein detected by Western could be specifically from cells in late prophase, and full length from earlier germ cell types (Figure 5D).

We also performed similar time-course experiments to analyse cryptic splicing of Brca2. This showed the same picture, that the Brca2 cryptic splice isoform comes from cells in meiotic prophase, and that there is a strong signal from normally spliced Brca2 from earlier germ cell types (new Figure 5*---*figure supplement 2).

We have also added additional discussion to our manuscript. Since we observe

splicing defects in 186 genes, the phenotype we observe may likely be due to the

additive loss of several or many genes.

> 4\) Whereas the RNAseq libraries are described in detail (ages, number of replicates, etc), there is scant information on the CLIP data. The authors are requested to add information on the age of samples, how many replicate tissues were used, how was the data processed and analyzed, how many genes have binding. It should also be mentioned how high-confidence binding sites were discriminated from experimental noise. Also, while AA-dinucleotides may be present in the top 10 pentamers, the quality of the CLIP information is unclear.

The CLIP analysis was carried out using one adult mouse, and was processed via the standard pipeline by Tomaz Curk using the icount software (http://icount.fri.uni-lj.si). We have now added in this extra information to the Methods section of our manuscript, and referenced the appropriate publication for icount.

> 5\) RNA binding maps representing different classes of splicing event would enhance the presentation of the CLIP analysis. For example, it would be interesting to see how hnRNP GT binding correlates with regulatory outcome from the RNA-seq analysis both for cryptic splice sites and for canonical types of alternative splicing like exon skipping events. Are similar features observed regarding mode of binding and regulation?

We added this data as new Figure 3*---*figure supplement 4. We carried out this analysis on our current HITS-CLIP data, but also added in an analysis using the predicted binding site from the HITSCLIP data as well.

> 6\) In Figure 6, the authors describe analysis of a minigene splicing reporter bearing the Kdm4d cryptic exon. A schematic of the minigene should be included in the Figure. The data shows that the cryptic exon is spliced in \~40% of reporter transcripts expressed in HEK293, and inclusion of the exon decreases significantly when hnRNP GT is expressed. A direct role for hnRNP GT in repressing the cryptic exon should be demonstrated by showing that mutation of AA dinucleotides abolishes hnRNP GT\'s ability to repress splicing (or bind the transcript). We propose to test this using an RRM negative hnRNPGT.

We added the schematic (new Figure 6A). In fact, we don't detect CLIP tags near the Kdm4d cryptic exon, although we do see them elsewhere on the gene (Figure 4A). Although lack of tags does not definitively exclude hnRNP GT binding to this region of the Kdm4d gene, it does suggest that hnRNP GT control of this cryptic exon could be largely through protein-protein interactions with another

splicing regulator such as Tra2β, rather than direct RNA-protein binding. We tested this idea by co-transfection experiments with full length hnRNP GT, and with an hnRNP GT variant from which the RNP1 motif in the RRM (RNA recognition motif) had been deleted (updated Figure 6B). Since both co-transfections blocked splicing inclusion of this cryptic exon this experiment supports the effect of hnRNP GT being largely not mediated by direct protein-RNA interactions by the RRM. Interestingly, although the ΔRNP1 version of hnRNP GT is able to repress splicing inclusion of the Kdm4d exon, it did not work quite as efficiently as the full length version of the protein. This leaves open some role for the RRM in regulating this Kdm4d exon.

We have also added in new data showing that RBMX is able to repress splicing of

the Kdm4d cryptic exon (updated Figure 6B). This supports the idea that RBMX

protein may fulfil the function of hnRNP GT prior to meiotic prophase, and so

contribute to the normal splicing patterns observed from testes before 14dpp.
